Pradimicins: A novel class of broad-spectrum antifungal compounds

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 1, 1997, Pages 93-97

  Walsh, T J ^a   Giri, N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MANNOSIDE; PRADIMICIN A;

ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; ASPERGILLUS; CANDIDA ALBICANS; CANDIDIASIS; CELL MEMBRANE; CONFERENCE PAPER; CRYPTOCOCCUS NEOFORMANS; DRUG STRUCTURE; FUSARIUM; HUMAN; MEMBRANE BINDING; MOULD; MYCOSIS; PRIORITY JOURNAL; ZYGOMYCETES;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIFUNGAL AGENTS; CHEMISTRY; HUMANS; MYCOSES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031059838     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01575126     Document Type: Conference Paper

References (27)

1. Graybill JR: New antifungal agents. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 402-412.
2. Walsh TJ, Pizzo PA: Treatment of systemic fungal infections: recent progress and current problems. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 460-475.
3. Lyman C, Walsh TJ: Systemically administered antifungal agents: a review of clinical pharmacology and therapeutic applications. Drugs 1992, 44: 9-35.
4. Georgopapadakou NH, Walsh TJ: Human mycoses: drugs and targets for emerging pathogens. Science 1994, 264: 371-372.
5. Gooday GW: The potential of novel antifungal drugs for the treatment of disease in the immunocompromised host. Expert Opinion on Investigational Drugs 1995, 4: 679-691.
6. Debono M, Gordee RS: Antibiotics that inhibit fungal cell wall development. Annual Review of Microbiology 1994, 48: 471-497.
7. Oki T, Tohru D: Pradimicins: potential antifungal and anti-HIV agents. Expert Opinion on Therapeutic Patents 1994, 4: 1483-1491.
8. Sawada Y, Tsuno T, Yamamoto H, Nishio M, Konishi M, Oki T: Pradimicins M, N, O, and P, new dihydrobenzo[a]naphthacenequinones produced by blocked mutants of Actinomadura hibisca P157-2. Journal of Antibiotics 1990, 43: 1367-1374.
9. Furumai T, Kakinuma S, Yamamoto H, Komiyama N, Suzuki K, Saitoh K, Oki T: Biosynthesis of the pradimicin family of antibiotics. I. Generation and selection of pradimicin-non-producing mutants. Journal of Antibiotics 1993, 46: 412-419.
10. Furumai T, Saitoh K, Kakushima M, Yamamoto S, Suzuki K, Ikeda C, Kobaru S, Hatori M, Oki T: BMS-181184, a new pradimicin derivative. Screening taxonomy, directed biosynthesis, isolation and characterization. Journal of Antibiotics 1993, 46: 265-274.
11. Saitoh K, Tenmyo O, Yamamoto S, Furumai T, Oki T: Pradimicin S, a new pradimicin analog. I. Taxonomy, fermentation and biological activities. Journal of Antibiotics 1993, 46: 580-605.
12. Saitoh K, Sawada Y, Tomita K, Tsuno T, Hatori M, Oki T: Pradimicins L and FL: new pradimicin congeners from Actinomadura verrucosospora subsp. neohibisca. Journal of Antibiotics 1993, 46: 387-409.
13. Sawada Y, Hatori M, Yamamoto H, Nishio M, Miyaki T, Oki T: New antifungal antibiotics pradimicins FA-1 and FA-2: D-serine analogs of pradimicins A and C. Journal of Antibiotics 1990, 43: 1223-1229.
14. Oki T, Kakushima M, Nishio M, Kamel H, Hirano M, Sawada Y, Konishi M: Water-soluble pradimicin derivatives, synthesis and antifungal evaluation of N,N-dimethyl pradimicins. Journal of Antibiotics 1990, 43: 1230-1235.
15. Tomita K, Nishio M, Saitoh K, Yamamoto H, Hoshino Y, Ohkuma H, Konishi M, Miyaki T, Oki T: Pradimicins A, B, and C: new antifungal antibiotics. I. Taxonomy, production, isolation and physico-chemical properties. Journal of Antibiotics 1990, 43: 755-762.
16. Sawada Y, Nishio M, Yamamoto H, Hatori M, Miyaki T, Konishi M, Oki T: New antifungal antibiotics, pradimicins D and E. Glycine analogs of pradimicins A and C. Journal of Antibiotics 1990, 43: 771-777.
17. Aburaki S, Okuyama S, Hoshi H, Kamachi H, Nishio M, Hasegawa T, Masuyoshi S, Imura S, Konishi M, Oki T: Synthesis and antifungal activity of pradimicin derivatives. Modifications of the aglycone part. Journal of Antibiotics 1993, 46: 1447-1457.
18. Kamachi H, Okuyama S, Hirano M, Masuyoshi S, Konishi M, Oki T: Antifungal activities of pradimicin derivatives modified at C4′-amino group. Journal of Antibiotics 1993, 46: 1246-1251.
19. Furumai T, Yamamoto H, Narita Y, Hasegawa T, Aburaki S, Kakushima M, Oki T: Microbial modification of pradimicins at C-11 leading to 11-0-demethyl- and 11-0-L-xylosylpradimicins A and FA-1. Journal of Antibiotics 1993, 46: 1589-1597.
20. Aaburaki S, Yamashifa H, Ohnuma T, Kamachi H, Moriyama T, Masuyoshi S, Kamel H, Konishi M, Oki T: Synthesis and antifungal activity of pradimicin derivatives. Modifications of the sugar part. Journal of Antibiotics 1993, 46: 631-640.
21. Ueki T, Numata K-I, Sawada Y, Nishio M, Ohkuma H, Toda S, Kamachi H, Fukagawa Y, Oki T: Studies on the mode of antifungal action of pradimicin antibiotics. II. D-mannopyranoside-binding site and calcium-binding site. Journal of Antibiotics 1993, 46: 455-477.
22. Numata K, Ueki T, Naito N, Yamada N, Kamasawa N, Oki T, Osumi M: Morphological changes in Candida albicans induced by BMY-28864, a highly water-soluble pradimicin derivative. Journal of Electron Microscopy 1993, 42: 147-155.
23. Ueki T, Oka M, Fukagawa Y., Oki T: Studies on the mode of antifungal action of pradimicin antibiotics. III. Spectrophotometric sequence analysis of the ternary complex formation of BMY-28864 with D-mannopyranoside and calcium. Journal of Antibiotics 1993, 46: 465-477.
24. Fung-Tomc JC, Minassian B, Huczko E, Kolek B, Bonner DP, Kessler RE: In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrobial Agents and Chemotherapy 1995, 39: 295-300.
25. Oki T, Tenmyo O, Hirano M, Tamatsu K, Kamei H: Pradimicins A, B, and C: new antifungal antibiotics. II. In vitro and in vivo biological activities. Journal of Antibiotics 1990, 43: 763-770.
26. Oki T, Kakushima M, Hirano M, Takahashi A, Ohta A, Masuyoshi S, Hatori M, Kamei H: In vitro and in vivo antifungal activities of BMS-181184. Journal of Antibiotics 1992, 45: 1512-1525.
27. Tanabe-Tochikura A, Tochikura TS, Blakeslee JR Jr., Olsen RG, Mathes LE: Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro. Antiviral Research 1992, 19: 161-172.